WP
Whiz Partners
Venture CapitalActiveInvests in companies in Japan, the U.S., Europe,and Asia, focusing on life science, bio-technology, and information technology fields
21
Investments
2
Exits
$100M
AUM
9.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Whiz Partners.
Investment Thesis & Strategy
Whiz Partners invests in life science, biotechnology, and information technology companies across various stages in Japan, the U.S., Europe, and Asia. They seek to invest in companies within the life science, biotechnology, and information technology fields.
Investment Activity
Deals per year over the last 1 years
10
2022Portfolio Companies
Selected investments from their portfolio of 21 companies
C
Cellino
Biotech · Series A, 2022
A
AetherAI
Healthcare · Series A, 2022
A
Ablaze Pharmaceuticals
Biotech · Series A, 2022
T
Trium
Biotech · Series A, 2022
A
Aillis
Healthcare · Series A, 2022
A
Ablaze Pharmaceuticals
Biotech · Series A, 2022
A
AetherAI
Healthcare · Series A, 2022
C
Cellino
Biotech · Series A, 2022
T
Trium
Biotech · Series A, 2022
A
Aillis
Healthcare · Series A, 2022
Notable Exits
CompanyTypeYearValue / Acquirer
SmartNewsAcquisition2024—
MercariIPO2018$1.2B
Frequently Asked Questions
Whiz Partners focuses on Series A, Series B, Series C+ stage investments.